G01N 2800/303
Eating disorders
Official title: Eating disorders, e.g. anorexia, bulimia
G01N2800/303 (Eating disorders) appears on 16 US grants and 27 published applications in this corpus.
Search patents in G01N- Granted patents
- 16
- Published applications
- 27
- Assignees
- 14
- Inventors
- 36
- Latest grant
- 1 Dec 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 5 |
| 2010 | 2 | 2 |
| 2011 | 2 | 2 |
| 2012 | 2 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects1 Dec 2020US 10,851,420 B2Alcediag
- Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects18 Jun 2019US 10,323,283 B2Alcediag
- Raising and diagnosing of serotonin level2 Oct 2018US 10,087,480 B2Gut Guide Oy
- Method for modulating appetite3 Feb 2015US 8,946,146 B2St. Vincent's Hospital Sydney Limited
- Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform8 Jul 2014US 8,771,953 B2Biocortech
- Method for modulating appetite3 Apr 2025US 2025/0109192 A1St. Vincent's Hospital Sydney Limited
- Method for modulating appetite4 Nov 2021US 2021/0340243 A1St. Vincent's Hospital Sydney Limited
- In vitro Transcription-Translation Metabolic Networks to Measure Quantity or Activity of Enzymes21 Oct 2021US 2021/0324442 A1Brigham Young University
- Editing profiling of pde8a pre -mrna: use as specific biomarker of adars activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects30 Jan 2020US 2020/0032338 A1Alcediag
- Method for modulating appetite6 Dec 2018US 2018/0346560 A1St. Vincent's Hospital Sydney Limited
Most cited
By later US patents
- Leptin-related peptides30US 6,777,388 B1CLF Medical Technology Acceleration Program, Inc. · 2004
- Method for modulating appetite27US 8,192,735 B2St. Vincent's Hospital Sydney Limited · 2012
- Method for modulating appetite19US 8,946,146 B2St. Vincent's Hospital Sydney Limited · 2015
- Neuropeptide Y receptor Y5 and nucleic acid sequences7US 5,965,392 ABayer Aktiengesellschaft · 1999
- Leptin-related peptides4US 7,186,694 B2Albany Medical College · 2007